O. Pate
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 6
- Genetics 5
- Chronic Lymphocytic Leukemia Research 5
- Co-authors
- Fernando Cabanillas (10 shared papers)Jorge Romaguera (9 shared papers)Peter McLaughlin (8 shared papers)A H Sarris (7 shared papers)Fredrick B. Hagemeister (4 shared papers)F Swan (3 shared papers)Anas Younes (7 shared papers)M Keating (2 shared papers)
- Journals
- Annals of Oncology (4 papers)Blood (3 papers)Journal of Clinical Oncology (2 papers)British Journal of Haematology (1 paper)Leukemia & lymphoma (1 paper)
- Partner nations
- United States
In The Last Decade
O. Pate
13 papers receiving 583 citations
Peers
Comparison fields: 5 of 51
- Genetics 234
- Pathology and Forensic Medicine 354
- Oncology 221
- Hematology 68
- Biomaterials 66
Countries citing papers authored by O. Pate
This map shows the geographic impact of O. Pate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Pate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Pate more than expected).
Fields of papers citing papers by O. Pate
This network shows the impact of papers produced by O. Pate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Pate. The network helps show where O. Pate may publish in the future.
Co-authors
The 25 scholars most cited alongside O. Pate, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 226 | |
| 2 | 2000 | 124 | |
| 3 | 1994 | 81 | |
| 4 | Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma. | 2000 | 56 |
| 5 | 1994 | 42 | |
| 6 | 1997 | 31 | |
| 7 | 2004 | 11 | |
| 8 | 1997 | 11 | |
| 9 | Paclitaxel (Taxol) for the treatment of lymphoma. | 1997 | 10 |
| 10 | 2007 | 6 | |
| 11 | 1996 | 6 | |
| 12 | 2006 | 5 | |
| 13 | 1997 | 5 |
About O. Pate
O. Pate is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Rheumatology and Hematology, having authored 13 papers that have together received 614 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (3 papers), Eosinophilic Disorders and Syndromes (3 papers), Cancer Treatment and Pharmacology (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Acute Lymphoblastic Leukemia research (1 paper) and CNS Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Genetics (234 citations), Pathology and Forensic Medicine (354 citations), Oncology (221 citations), Hematology (68 citations) and Biomaterials (66 citations). O. Pate has collaborated with scholars based in United States. Frequent co-authors include Fernando Cabanillas, Jorge Romaguera, Peter McLaughlin, A H Sarris, Fredrick B. Hagemeister, F Swan, Anas Younes, M Keating, Maria Alma Rodriguez and Hagop M. Kantarjian. Their work appears in journals such as Annals of Oncology, Blood, Journal of Clinical Oncology, British Journal of Haematology and Leukemia & lymphoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.